Severe Wasp Season and Financial Factors Lead to Epi-Pen Shortage in Austria

Austria is facing a critical shortage of Epi-Pens, the essential emergency medication for individuals with severe allergies, particularly to wasp stings. The situation is exacerbated by an exceptionally high number of wasps this season, leading to increased demand for the life-saving devices.

Pharmacists like Gerhard Kobinger in Graz have highlighted that the scarcity is not solely due to the "wasp year." A significant factor is the manufacturer's pricing strategy, which prioritizes markets where they can achieve higher profits. This means Austria often faces longer waiting times for resupply compared to other nations.

“

We have been promised that the Epi-Pen will be available again in the last week of August, first week of September.

Kobinger expressed cautious optimism, noting a promise of Epi-Pen availability in late August or early September. However, he stressed that the medication is only considered truly available once it is physically present in pharmacies. For those with severe reactions, including circulatory problems or breathing difficulties, Kobinger strongly recommends seeking advice from a specialist regarding immunotherapy. This treatment involves regular injections of wasp venom over an extended period, aiming to desensitize the body and has a success rate of over 90%, with costs typically covered by health insurance.

“

However, one should only believe that when it is actually there.